Medicine guide

NEUPRO

As listed in the register: NEUPRO 8 mg/24 h, dispositif transdermique

18 mg · dispositif

  • Prescription only
Active substance
Rotigotine
Made by
UCB PHARMA BELGIQUE

Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.

What it is for

Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet

Same active substance, strength and form in other countries

Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.

Medicine passport: one printable page to show a pharmacist abroad

United StatesNo exact match for this strength and form

European UnionNo exact match for this strength and form

CanadaNo exact match for this strength and form

NetherlandsNo exact match for this strength and form

Details

Made byUCB PHARMA BELGIQUE
Active substanceRotigotine
Strength18 mg
Formdispositif
Routetransdermique
Dispensing (as stated by the register)liste I
MarketedYes, according to the register
Authorisation procedureProcédure centralisée
EU numberEU/1/05/331
Name in the registerNEUPRO 8 mg/24 h, dispositif transdermique
Packs30 sachet(s)-dose(s) copolymère d'éthylène aluminium polyéthylène basse densité (PEBD) papier polyéthylène de 1 dispositif(s)
CIS61578613
CIP133400937721578

Source: Base de données publique des médicaments · 2026-09-30 · not reviewed by a clinician

Source : Base de données publique des médicaments (ANSM / Ministère de la Santé), sous Licence Ouverte. Reuse terms: Licence Ouverte / Open Licence (Etalab).

Other strengths and forms

4 products are sold under this name. Grouped by form; a number on a strength means several companies make it.

Same active substance

These contain the same substance. That does not mean one can replace another — ask a pharmacist.